Core technologies
01Angiogenesis candidate discovery technology
Angiogenesis inhibitory activity assay
Angiogenesis stimulating activity assay
Various in vitro and in vivo assay systems
Numerous angiogenesis-dependent animal disease models
02Botanical drug development technology
Screening of natural functional materials
Analysis and evaluation of the active ingredients of botanical drugs
Verification of safety and efficacy
Identification of MOA and pharmacological action
03Antibody drug development technology
Establish human naïve scFv Library and Nanobody Library
Establish animal cell expression system
04Plenty of clinical trial experiences
Experiences in drug development and clinical trials for various angiogenesis-related diseases
Completed phase 2 clinical trial for abdominal obesity drug and got approval for the phase 3 IND
Got approval for phase 2 clinical trials and are now conducting the clinical trials
Got approval for specific health functional food, with health claim of visceral fat reduction
05Domestic and overseas patents
Holds 60 domestic and overseas patents for angiogenesis inhibitors
Possess various angiogenesis inhibitors such as botanical drugs, protein and single compounds
File the subsequent patents based on company's evergreening strategy